Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for VCEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 51.17M
March 31, 2026 51.01M
December 31, 2025 50.62M
September 30, 2025 50.55M
June 30, 2025 50.44M
March 31, 2025 50.25M
December 31, 2024 49.63M
September 30, 2024 49.26M
June 30, 2024 48.86M
March 31, 2024 48.49M
December 31, 2023 47.83M
September 30, 2023 47.68M
June 30, 2023 47.62M
March 31, 2023 47.51M
December 31, 2022 47.25M
September 30, 2022 47.20M
June 30, 2022 47.14M
March 31, 2022 47.08M
December 31, 2021 46.88M
September 30, 2021 46.77M
June 30, 2021 46.58M
March 31, 2021 46.22M
December 31, 2020 45.80M
September 30, 2020 45.32M
June 30, 2020 45.19M
Date Value
March 31, 2020 44.96M
December 31, 2019 44.86M
September 30, 2019 44.52M
June 30, 2019 44.07M
March 31, 2019 43.82M
December 31, 2018 43.58M
September 30, 2018 43.17M
June 30, 2018 42.68M
March 31, 2018 36.50M
December 31, 2017 35.86M
September 30, 2017 34.85M
June 30, 2017 32.77M
March 31, 2017 32.72M
December 31, 2016 31.60M
September 30, 2016 22.74M
June 30, 2016 22.68M
March 31, 2016 22.64M
December 31, 2015 23.79M
September 30, 2015 23.79M
June 30, 2015 23.79M
March 31, 2015 23.79M
December 31, 2014 23.79M
September 30, 2014 23.79M
June 30, 2014 7.019M
March 31, 2014 6.245M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 1.767B
ADMA Biologics, Inc. 225.36M
Kyntra Bio, Inc. 4.049M
Conexeu Sciences, Inc. 26.76M
ACADIA Pharmaceuticals, Inc. 172.13M